- Home
- CRDF vs TMQ Comparison
CRDF vs TMQ Comparison
Compare CRDF & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- TMQ
- Stock Information
- Founded
- CRDF 1999
- TMQ 2004
- Country
- CRDF United States
- TMQ Canada
- Employees
- CRDF N/A
- TMQ N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- TMQ Precious Metals
- Sector
- CRDF Health Care
- TMQ Basic Materials
- Exchange
- CRDF Nasdaq
- TMQ Nasdaq
- Market Cap
- CRDF 233.5M
- TMQ 226.7M
- IPO Year
- CRDF N/A
- TMQ N/A
- Fundamental
- Price
- CRDF $4.04
- TMQ $1.70
- Analyst Decision
- CRDF Strong Buy
- TMQ
- Analyst Count
- CRDF 6
- TMQ 0
- Target Price
- CRDF $11.92
- TMQ N/A
- AVG Volume (30 Days)
- CRDF 1.4M
- TMQ 464.8K
- Earning Date
- CRDF 08-07-2025
- TMQ 07-10-2025
- Dividend Yield
- CRDF N/A
- TMQ N/A
- EPS Growth
- CRDF N/A
- TMQ N/A
- EPS
- CRDF N/A
- TMQ N/A
- Revenue
- CRDF $587,000.00
- TMQ N/A
- Revenue This Year
- CRDF N/A
- TMQ N/A
- Revenue Next Year
- CRDF N/A
- TMQ N/A
- P/E Ratio
- CRDF N/A
- TMQ N/A
- Revenue Growth
- CRDF N/A
- TMQ N/A
- 52 Week Low
- CRDF $2.01
- TMQ $0.47
- 52 Week High
- CRDF $5.64
- TMQ $2.09
- Technical
- Relative Strength Index (RSI)
- CRDF 65.93
- TMQ 71.17
- Support Level
- CRDF $3.07
- TMQ $1.30
- Resistance Level
- CRDF $4.22
- TMQ $1.74
- Average True Range (ATR)
- CRDF 0.22
- TMQ 0.10
- MACD
- CRDF 0.08
- TMQ 0.04
- Stochastic Oscillator
- CRDF 87.35
- TMQ 90.91
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.